rhodamine b has been researched along with enbucrilate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gelperina, S; Heifets, L; Higgins, MP; Kisich, KO; Oganesyan, E; Shipulo, E; Wilson, S | 1 |
Appold, L; Fokong, S; Jorge, S; Kiessling, F; Koczera, P; Lammers, T; Resch-Genger, U; Storm, G; Theek, B; van Zandvoort, M; Wu, Z | 1 |
Appold, L; Dasgupta, A; Fokong, S; Iranzo, O; Kiessling, F; Koczera, P; Kuehne, AJC; Lammers, T; Liu, M; Ojha, T; Pathak, V; Pich, A; Shi, Y; van Zandvoort, M; Wu, Z | 1 |
3 other study(ies) available for rhodamine b and enbucrilate
Article | Year |
---|---|
Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Bacillus subtilis; Biological Assay; Cells, Cultured; Drug Compounding; Enbucrilate; Fluoroquinolones; Humans; Macrophages; Moxifloxacin; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Quinolines; Rhodamines; Suspensions | 2007 |
Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles.
Topics: Acoustics; Animals; Cell Line, Tumor; Coumarins; Cyanoacrylates; Drug Delivery Systems; Enbucrilate; Fluorescent Dyes; Mice; Microbubbles; Microscopy, Fluorescence; Neoplasms; Rhodamines; Thiazoles; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
PBCA-based polymeric microbubbles for molecular imaging and drug delivery.
Topics: Animals; Antibodies; Biotin; Brain; Carotid Arteries; Cell Line, Tumor; Dextrans; Drug Delivery Systems; E-Selectin; Enbucrilate; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Male; Mice, Nude; Microbubbles; Molecular Imaging; Neoplasms; Neovascularization, Pathologic; Rhodamines; Streptavidin; Ultrasonic Waves; Ultrasonography; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor Receptor-2 | 2017 |